NEVVI Medicare utilization intelligence
or

← back

Provider profile

PIERSON, ASHLEY PA-C

Physician Assistant · NPI 1609213800 · JOHNSON CITY, TN

1
Groups
21
Codes · 2024
3,522
Disclosed services

PIERSON, ASHLEY is a Physician Assistant in JOHNSON CITY, TN, a member of 1 medical group, who billed 21 distinct codes to Medicare Part B in 2024.

Groups: KNOXVILLE DERMATOLOGY GROUP PC (KNOXVILLE, TN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

3,522
disclosed services
21
codes billed to Medicare Part B
Prior year · CY2023 2,419 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
11102 Biopsy of related skin growth, first growth
17110 Destruction of skin growth, 1-14 growths
11103 Biopsy of related skin growth, each additional growth
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
96920 Treatment of inflammatory skin disease using laser, less than 250.0 sq cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
17004 Destruction of precancer skin growth, 15 or more growths
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
11900 Injection into skin growth, 1-7 growths
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
11200 Removal of skin tag, 1-15 skin tags
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
69100 Biopsy of ear

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.